Evidence map›Paper›PMID 41744410›Full record

ArticleHuman vaccines & immunotherapeutics2026

Safety and health-related quality of life following maternal respiratory syncytial virus (RSV) and diphtheria-tetanus-acellular pertussis (DTaP) vaccinations.

Taito Kitano, Nami Kurosawa, Shioka Watanabe, Kana Takeda, Satoko Ishibashi, Hiroko Fukui, Sonomi Kurose, Mayuka Ikeda, Masato Kano, Go Kanzaki and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Taito KitanoDepartment of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.ORCID 0000-0003-0623-066X
Nami KurosawaDepartment of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.
Shioka WatanabeDepartment of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.
Kana TakedaDepartment of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.
Satoko IshibashiDepartment of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.
Hiroko FukuiDepartment of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.
Sonomi KuroseDepartment of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.
Mayuka IkedaDepartment of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.
Masato KanoDepartment of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.
Go KanzakiDepartment of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.
Toshiyuki SadoDepartment of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.
Ayako OhgitaniNeonatal Intensive Care Unit, Nara Prefecture General Medical Center, Nara, Japan.
Sayaka YoshidaDepartment of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maternal respiratory syncytial virus (RSV) and pertussis vaccinations are recommended in some countries. While Tdap is widely used in pregnant women, DTaP is the approved pertussis vaccine in Japan. This study aimed to evaluate the safety of maternal RSV and DTaP vaccination, including reactogenicity and pregnancy and neonatal outcomes. This observational study included pregnant women vaccinated with RSV or DTaP. Reactogenicity and health-related quality of life were assessed daily. Pregnancy and neonatal outcomes, including preterm delivery, hypertensive disorder of pregnancy (HDP), cesarean section, low birth weight and NICU admission, were compared with an unvaccinated historical cohort. A total of 252 RSV-vaccinated and 159 DTaP-vaccinated pregnant women were included. Twin pregnancy occurred in 13.9%, 7.4%, and 6.6% of the RSV-vaccinated, DTaP-vaccinated, and unvaccinated cohorts. Grade 1-2 local adverse events occurred in 108 (46.1%) RSV-vaccinated and 102 (75.0%) DTaP-vaccinated women (

Indexed as

immunizationpertussispregnancyRespiratory syncytial virustwin

Identifiers

PMID41744410
PMCPMC12947551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.